Web16 mei 2024 · 南京明德,Medshine及核心研发人员。 涉及靶点: TLR-7 (多款乙肝) 核衣壳蛋白调节剂 三/四代EGFR URAT1 PARP BTK CDK4/6 食欲素受体拮抗剂 mTOR/PI3K EV71 ALK/ROS1 多款流感 RSV 丙肝 PDE4 NASH多个靶点 PDE9 IAP CRTH2 KRAS-G12C SHP2 MEK ERK S1P1 Wee1 抗癫痫 地佐辛改构 长春西汀改构 EZH2 HDAC FGFR AKT Xa抑 … Web19 aug. 2024 · We describe the opportunities and limitations of the helicase-primase inhibitor patent portfolio from Phaeno Therapeutics and propose the structure of their …
Patents Assigned to MEDSHINE DISCOVERY - Justia Patents Search
Web10 apr. 2024 · Tnc fl/fl mouse line was purchase from Cyagen Biosciences Inc ... (MedShine, cat: 120503) for 6 consecutive days unless otherwise noted (62.5 mg for ... Discover content. Journals A-Z; Articles by ... WebHelicase-primase inhibitors from Medshine Discovery Inc. (WO2024/127207 and WO2024/007355) for the treatment of herpes simplex virus infections – structure … blueberry cupcakes with blueberry buttercream
Xuzhou Medshine Technology Co.,Ltd
Web12 jan. 2024 · Jan. 12, 2024 Jiangsu Chia Tai Tianqing Pharmaceutical Group Co. Ltd. and Medshine Discovery Inc. have identified benzoxazinone derivatives acting as mineralocorticoid receptor (MR) antagonists reported to be useful for the treatment of diabetic nephropathy. BioWorld Science Nephrology Patents Web3 apr. 2024 · BAIYUNSHAN PHARMACEUTICAL GENERAL FACTORY, MEDSHINE DISCOVERY INC. Inventors: Jiansong WANG, Zhengxia CHEN, Zhibo LUO, Meibi DAI, Yang ZHANG, Shuhui CHEN, Yingxia BAO, Wei WANG, Zhoufan XIE NITROGEN-CONTAINING SPIRO DERIVATIVE AS RET INHIBITOR Publication number: 20240244507 WebDisclosed in the present invention are a series of heterocycle-substituted pyrimidine derivatives, and specifically disclosed are a compound as represented by formula (I) and a pharmaceutically acceptable salt thereof. blueberry cupcake tibia